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from Case of  
Autochthonous 
Lyme Arthritis
To the Editor: The first Lyme 
borreliosis (LB) case reported to be 
acquired in California occurred in 
1978 (1). During the past 10 years, 
744 confirmed LB cases were reported 
in California; 419 (56.2%) were likely 
acquired in-state. The highest inci-
dence of this disease occurs in north-
ern coastal California, in locations 
such as Santa Cruz County (2), where 
habitat supports yearlong activity of 
the tick vector Ixodes pacificus (3,4).
Existing data describe the genet-
ic diversity of the LB agent Borrelia 
burgdorferi among ticks in Californa 
(5,6), but few instances of direct de-
tection and genetic characterization of 
B. burgdorferi sensu stricto in samples 
from humans are documented in Cali-
fornia. B. burgdorferi has been iso-
lated from skin biopsy samples of 3 
patients in California in whom LB was 
diagnosed (1). Seinost et al. genotyped 
strains isolated in the United States, 
including 7 isolates identified in Cali-
fornia from skin, blood, or cerebrospi-
nal fluid, but no documented exposure 
information was available (7). Girard 
et al. genotyped B. burgdorferi in 10- 
to 12-year-old stored serum samples 
collected from 22 northern California 
residents, some of whom were as-
ymptomatic at time of collection. Of 
22 PCR-positive specimens, 21 had 
the single laboratory type strain B31 
genotype (3).
A 12-year-old resident of Santa 
Cruz County, California, came to the 
emergency department of Dominican 
Hospital in September 2012 with a 
swollen, painful right knee and mildly 
painful right hip. The patient’s family 
reported that LB had been diagnosed 
by a local physician. Illness onset was 
in May 2010; symptoms consisted of 
recurrent knee swelling and pain last-
ing several days every 4–5 months 
and positive serologic test results for 
B. burdorferi (not available). The pa-
tient had not traveled outside of Cali-
fornia during the preceding 6 years. 
In May 2011, an IgG Western blot of 
the patient’s serum that was processed 
at a commercial laboratory showed 
immunoreactive bands of 18, 23, 28, 
30, 39, 41, 45, 58, 66, and 93 kDa. In 
both 2010 and 2011, the patient’s fam-
ily had chosen to give the patient un-
specified herbal treatments instead of 
antibacterial drugs.
On physical examination in the 
emergency department, the patient’s 
right knee was swollen; knee flexion 
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was reduced to 30°. The right hip was 
painful on rotation. Serum laboratory 
values included a leukocyte count of 
7,000/mL, hematocrit 33%, and eryth-
rocyte sedimentation rate of 73mm/h. 
Plain radiograph images of the right 
hip did not show any abnormalities; the 
radiograph of the right knee showed 
suprapatellar effusion (Figure). Right 
knee aspiration yielded 115 mL of 
cloudy yellow fluid; laboratory tests 
showed a leukocyte count of 59,750/
mL and protein level 5 g/dL; no crystals 
were noted. Results of routine bacterial 
culture of synovial fluid were negative. 
Amoxicillin was prescribed for a sus-
pected septic joint and was taken for 
1 week. Nine months later, the patient 
was reportedly asymptomatic and had 
returned to normal activity.
Right knee synovial fluid was sent 
to ARUP Laboratories (Salt Lake City, 
UT, USA); results were positive for the 
B. burgdorferi sensu lato recA gene by 
use of a proprietary qualitative PCR 
procedure. At the University of Cali-
fornia, Irvine, we thawed another ali-
quot of synovial fluid, which had been 
frozen without cryoprotectant, and 
inoculated samples into BSK II me-
dium (8). After incubation for 2 weeks 
at 34°C, no spirochetes were noted. 
We subjected another 100 mL ali-
quot to DNA extraction using DNeasy 
Blood and Tissue Kit and the QIA-
cube apparatus (QIAGEN, Valencia, 
CA, USA). We used multiplex quan-
titative PCR (qPCR) and primers and 
specific probes for the 16S ribosomal 
RNA genes of LB group species and 
for relapsing fever group species of 
Borrelia in 2 replicates as described 
by Barbour et al. (9). By qPCR, there 
were 18 gene copies of an LB group 
species in 1 replicate and 23 copies in 
the other. The qPCR results for relaps-
ing fever group species, including B. 
miyamotoi and B. hermsii, which are 
enzootic in parts of California, were 
negative. We genotyped the ospC al-
lele and 16S–23S intergenic spacer 
(IGS) using PCR amplification of 
each locus and direct sequencing as 
described by Travinsky et al. (6). Se-
quencing of the targeted PCR products 
showed that the ospC allele was type 
Hb and the IGS genotype was 13.
Two years of untreated relapsing 
pauciarticular arthritis of the knee and 
hip, a B. burgdorferi–positive West-
ern blot, and laboratory detection of 
B. burgdorferi from synovial fluid by 
PCR in 2 different laboratories leads 
us to conclude that the patient had 
Lyme arthritis. This patient likely ac-
quired the infection locally. The prev-
alence of B. burgdorferi in nymphal 
I. pacificus ticks (range 4%–10%) in 
Santa Cruz County, and >10% of the 
geographic area of the county is cat-
egorized as being at high acarologic 
risk for LB (4). To our knowledge, 
the combination of ospC allele Hb 
and IGS genotype 13 has been identi-
fied only in California to date (6,8). A 
type “H” ospC type was reported from 
synovial fluid from LB patients from 
the eastern United States (10), but in 
the absence of IGS determination, this 
was probably type Ha, which is more 
typical of that region (8). The addi-
tion of the IGS locus to ospC alleles 
provides a precise approach to charac-
terize genetic diversity and potential 
origin of B. burgdorferi in human tissue.
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To the Editor: Baylisascaris 
procyonis, an intestinal roundworm 
that infects raccoons (Procyon lotor), 
causes fatal or severe neural larva mi-
grans in animals and humans (1,2). 
Globally, ≈130 species of wild and do-
mesticated animals are susceptible (2). 
Infections in humans typically occur in 
children who have the disorders pica 
or geophagia and ingest B. procyonis 
eggs in items contaminated with rac-
coon feces (3). Clinical manifestations 
include ocular disease, eosinophilic 
encephalitis, and eosinophilic cardiac 
pseudotumors; severe infection can 
lead to death. Since 1984, ≈24 cases 
of B. procyonis–related human neu-
ral larva migrans have been reported, 
mainly in the United States (1,3–5; 
K.R. Kazacos, pers. comm.). Despite 
few cases among humans, lack of ef-
fective treatment and widespread 
distribution of infected raccoons in 
close association with humans make 
B. procyonis a potentially serious 
public health threat (2,6). The current 
distribution of B. procyonis is poorly 
recorded in Asia (2,7), except for Ja-
pan (8). We describe B. procyonis in-
fections among raccoons in China as 
part of a series of ongoing surveys of 
helminthic zoonoses linked to captive 
exotic animals in zoologic gardens 
(ZGs) in China.
More than 90% of raccoons in 
China (n >320) are raised as exotic or-
namental animals in 18 ZGs. During 
2011–2013, we collected 2×308 fe-
cal samples (i.e., 1 repeat within each 
sampling) from 277 raccoons in 12 
randomly selected ZGs (online Tech-
nical Appendix Figure 1, wwwnc.
cdc.gov/EID/article/20/12/14-0970-
Techapp1.pdf). Samples were stored 
in individual plastic bags at –20°C 
until use. We examined raccoons (n = 
31) at the Sichuan ZGs twice, in June 
2012 and May 2013. We identified B. 
procyonis eggs in feces using morpho-
logic and molecular analyses (1,2,9). 
The nuclear first internal transcribed 
spacer (428 bp) and mitochondrial 
cytochrome c oxidase subunit 1 (cox-
1, 938 bp) genes in each sample were 
PCR-amplified and sequenced. B. 
procyonis infection was confirmed by 
sequencing and phylogenetic analyses 
of both genes (7,9). We reexamined 
≈60% of fecal samples to validate 
results. Prevalence (95% CI) was cal-
culated for the overall population and 
independently for female, male, ju-
venile, and adult raccoons. We deter-
mined differences between the tested 
ZG prevalence and prevalence by sex 
or age of raccoons using χ2 or Fish-
er exact tests in SAS (SAS Institute, 
Cary, NC, USA); p values <0.05 were 
considered significant.
Building on egg-based morpho-
logic characterization and internal 
transcribed spacer 1 and cox-1 gene-
based phylogenies using neighbor-
joining trees (online Technical Appen-
dix Figure 2), we found B. procyonis 
in raccoon feces from 5/12 ZGs (42%; 
95% CI 14%–70%), including 2 in the 
most densely populated provinces, 
Henan and Sichuan. More infections 
were found in western than central 
and eastern ZGs (4/6 and 1/6, respec-
tively; Table, online Technical Ap-
pendix Figure 1) (p = 0.079). Fecal 
samples of 35 raccoons (13%; 95% CI 
9%–17%) tested positive for B. procy-
onis. The mean intensity of egg shed-
ding was 5,000 eggs per gram (range 
800–11,200 eggs per gram; data not 
shown). No significant difference was 
observed in the intensity of shedding 
by comparing sex and age of animals, 
and no significant differences were 
noted in the mean prevalence between 
female and male raccoons (12% ver-
sus 14%; p = 0.677) or between adult 
and juvenile animals (13% versus 
10%; p = 0.536).
This investigation documents the 
presence and prevalence of B. procyonis 
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